Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited)

v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating expenses    
Research and development $ 320,986 $ 25,000
General and administrative 1,194,081 1,226,361
Total operating expenses 1,515,067 1,251,361
Operating loss (1,515,067) (1,251,361)
Other expense (income)    
Change in fair value of derivative liabilities 12,820,618 (977,493)
Fair value of derivative liabilities in excess of proceeds 322,644 7,174,634
Financing transaction costs   137,191
Loss on extinguishment of secured convertible promissory note - related party   590,392
Interest expense 116,063 37,708
Net loss and comprehensive loss $ (14,774,392) $ (8,213,793)
Basic and diluted net loss per common share (in dollars per share) $ (0.11) $ (0.09)
Weighted average shares of common stock outstanding: basic and diluted (in shares) 132,729,246 88,632,979